Sponsored by:
Strategies for Robust Process Characterization and Validation to Accelerate Biologics Manufacturing
Establishing strong process characterization and validation early is critical to ensuring biologics are developed efficiently, in compliance, and ready for scale—but these steps are often underestimated and overlooked until late in development.
Establishing strong process characterization and validation early is critical to ensuring biologics are developed efficiently, in compliance, and ready for scale—but these steps are often underestimated and overlooked until late in development. In this webinar, experts from Thermo Fisher Scientific will share real-world case studies showing how robust, data-driven process design accelerates validation readiness and reduces manufacturing risk. Learn how an integrated approach to process understanding can help you move faster from development to commercial success.
Experts from Thermo Fisher Scientific will share real-world case studies demonstrating how efficient tech transfer, analytical, and manufacturing strategies have helped biopharma innovators achieve validation readiness faster—without compromising quality or compliance. Through these examples, participants will learn:
- Key strategies for a smooth technliogy transfer.
- The design and execution of robust process characterization and validation.
- Bridge development and commercial manufacturing with data-driven validation approaches.
Who Should Attend :
- Emerging and mid-sized or large biotech and pharma companies advancing biologics through late-stage development.
- CMC leads, process development scientists, engineering scientists, and QA/regulatory professionals.
- Decision-makers seeking to optimize scale-up, ensure compliance, and prepare for commercial manufacturing.
